Argent Biopharma (RGTLF)
OTHER OTC:RGTLF
Holding RGTLF?
Track your performance easily

Argent Biopharma (RGTLF) Ownership - Who Owns Argent Biopharma?

29 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 12, 2024
Roby Reuven Zomer
Chief Executive Officer
xxxxxxxxxxxxx
AU$503400
Apr 10, 2024
Amir Polak
Chief Technical Officer
xxxxxxxxxxxxx
AU$2385

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
53,000,000Insider109.49%12,137,000
30,960,558Insider63.96%7,089,968
20,979,628Insider43.34%4,804,335
19,718,602Insider40.74%4,515,560
11,780,296Insider24.34%2,697,688
9,544,190Insider19.72%2,185,620
4,970,370Insider10.27%1,138,215
4,600,000Insider9.50%1,053,400
3,185,148Insider6.58%729,399
1,993,427Insider4.12%456,495

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Argent Biopharma (RGTLF)?
Currently, no data Available
What percentage of Argent Biopharma (RGTLF) stock is held by institutional investors?
Currently, no data Available
What percentage of Argent Biopharma (RGTLF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Argent Biopharma (RGTLF)?
Nativ Segev owns the most shares of Argent Biopharma (RGTLF).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis